Virulence Factors and Pathogenicity of Mycobacterium by Echeverria-Valencia, Gabriela et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 12
Virulence Factors and Pathogenicity of Mycobacterium
Gabriela Echeverria-Valencia,
Susana Flores-Villalva and Clara I. Espitia
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.72027
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Gabriela Echeverria-Valencia, Susana Flores-Villalva and 
Clara I. Espitia
Additional information is available at the end of the chapter
Abstract
Virulence, is referred as the ability of a pathogen to cause disease, and for mycobacteria 
it depends on their ability to reside within host cells and evade the microbicidal mech-
anisms of macrophages. The outcome of tuberculosis (TB) infection is highly variable 
and it seems that the closest relationship between the Mycobacterium genre and humans 
has shaped the mycobacterial genome to encode bacterial factors that reflects a highly 
evolved and coordinated program of immune evasion strategies that interfere with 
both innate and adaptive immunity causing disease even in fully immunocompetent 
host. Although Mycobacterium tuberculosis (MTB) does not have classical virulence fac-
tors, it has described many virulence-associated genes and virulence lifestyle genes from 
Mycobacterium tuberculosis complex (MTBC). In this chapter, we describe the most impor-
tant gene/molecule involved in the host defense modulation response, also the plethora 
of strategies to evade immune mechanisms of macrophage. We review the main genes 
whose inactivation in the mycobacterial genome leads to a measurable loss in virulence 
in the different validated TB models.
Keywords: virulence factor, pathogenicity, mycobacterium, cell wall, immune evasion, 
tuberculosis
1. Introduction
Tuberculosis (TB) is mostly caused by Mycobacterium tuberculosis (MTB) and Mycobacterium 
africanum, both members of the Mycobacterium tuberculosis complex (MTBC), a group of 
closely related species which are adapted to human and animals. The outcome of TB infection 
is highly variable and is determined by the response of the immune system and environmen-
tal variables, but a deeper knowledge of the global genomic diversity in the MTBC suggests 
that bacterial factors are also involved. To better understand the virulence mechanisms of the 
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MTBC, it is necessary to define what constitutes a virulence gene. There are a wide variety 
of conditions and parameters to define it, but undoubtedly a true virulence gene codifies for 
factors or enzymes producing factors that are involved in the interaction with the host, and 
are directly responsible for the pathological damage during infection and are absent in non-
pathogenic bacteria. Perfect examples of virulence genes are the toxins produced by Vibrio 
cholera and Escherichia coli O157. MTB does not have classical virulence factors; however, many 
virulence-associated genes and virulence lifestyle genes from MTBC have been described [1]. 
Virulence-associated genes, are genes coding for factors that regulate expression of virulence 
genes and activate virulence factors by translational modifications, processing or secretion; 
whereas, virulence lifestyle genes codifies for factors that enable colonization of the host, 
enable evasion of the host immune system and enable intracellular survival. Besides, unlike 
other pathogens, MTB virulence is directly linked to its transmission. Thus its virulence can 
be measured through (1) the ability of the bacteria to survive the host immune response, 
(2) their capacity to cause lung damage and (3) to be successfully transmitted to infect a 
new host [2]. MTB pathogenicity, defined by its ability to cause disease in a host organism, 
has co-evolved with its physiology as specie. Initial infection is mainly through respiratory 
tract, here the alveolar macrophages are the most common cell type infected by MTB and 
the inflammatory signals arising from infection promote the influx of additional monocytes 
and macrophages, which become infected as well. Inflammation is required for initial control 
of infection but can also cause extensive tissue damage. Moreover, the bacteria exploit the 
host inflammatory signals to spread to other individuals. Because of that, it is believed that 
its pathogenicity is likely to have evolved from its specific adaptations to host immunity. 
In fact, Comas et al., showed that a large majority of the T cell epitopes, representatives of 
several linages of the MTBC, had high sequence conservation, indicating that there is a high 
strong selection pressure to keep those T cell epitopes unchanged, which suggest that MTBC 
might benefit from being recognized by T cells, because as referred above, MTB virulence 
depends on its transmission [3]. While a significant number of genes have been shown to be 
important for the progression of TB, we focus on only few examples. We place emphasis in 
those genes whose inactivation in the mycobacterial genome leads to a measurable loss in 
virulence in the different validated TB models. The mycobacterial cell wall and envelope are 
unique among bacteria and many of their components are known to play an important role in 
the TB pathogenesis. Taking these concepts into consideration, we analyzed separately their 
lipids, secreted proteins and systems that play a role in the synthesis of various cell surface 
molecules. Thereafter, we describe the main proteins that inhibit antimicrobial effectors of 
the macrophage.
2. Models for measuring MTB virulence
MTB virulence is studied in cell culture and animals models. Thus different parameters of patho-
genicity according the TB models are used. A hallmark of MTB pathogenicity is the ability to 
infect and survive within macrophages; thus, primary macrophages and cell lines are used to 
analyze the virulence of MTB and mutants at the early stages of infection. Primary macrophages 
are more representative of the natural in vivo situation but they are difficult to propagate to 
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sufficient numbers for virulence experiments. Primary murine bone marrow-derived macro-
phages (BMDMs) and human macrophages from peripheral blood monocytes (HMDMs) are 
the most common primary macrophages used, whereas the immortalized cell lines THP-1, J774 
and MH-S cells have been widely used to study MTB-macrophage interactions. Data from both 
cell type should be interpreted with care because the response of MTB to intracellular environ-
ment can vary greatly depending on the cell type used [4]. In addition to evaluate the survival, 
replication and the intracellular bacillary load of MTB in the macrophages models, it is possible 
to study some of its mechanisms to counteract the macrophage microbicide ability, such as (1) 
the resistance to reactive oxygen/nitrogen intermediates (ROI/RNI), (2) the phagosome arresting 
and (3) the inhibition of apoptosis [1]. On the other hand, in animal models it is possible to study 
all the stages of the TB infection, although their ability to replicate the different aspects of human 
TB pathology varies. The major models used are mice, guinea pigs and rabbits [5]. Mice is the 
most frequent in vivo model used because of their well-characterized genetics and the huge col-
lection of immunological reagents as well as the existence of inbred strains, their susceptibility 
to MTB is low and their pathology is unlike that in humans [5]. Guinea pigs are very sensitive to 
MTB and develop a disease with multiple similarities to human disease, such as lung necrosis, 
lymphadenopathy and disease dissemination. And the rabbit model develops lung granulomas 
which closely resemble the histology of human TB when they are infected with M. bovis, due to 
their size, high cost and lack of immunological reagents that make the model less tractable than 
mice. The close similarity between MTB and M. bovis make the cattle model a very attractive way 
to study TB pathogenesis. The bovine TB disease pathology is very similar to human TB, with 
caseating granulomas in the lungs and a similar latent phase in the infection. The major advan-
tage of the cattle model is the possibility to conduct field trials, which makes it very attractive 
for vaccine studies [6]. The non-human primate model are the only TB model that develops all 
the clinical disease states found in human TB, and although its use has been invaluable in TB 
research, it is limited by ethical concerns and high cost. The most important parameters associ-
ated with virulence in animal models, besides mortality and morbidity, are: the bacterial load, 
the numbers of bacteria found in the infected host after the initial infection, histopathological 
changes and inflammatory responses. Finally, it is important to mention that zebrafish model 
has also been shown to be very useful to elucidate the early events of the mycobacterial infection, 
particularly in the study of the mechanisms of granuloma formation and its role in controlling 
the infection [5]. Infection of zebrafish with M. marinum, a closest relative of MTBC, resembles 
many aspects of human tuberculosis; in fact, crucial virulence factors, host genes and immune 
cell types are conserved in the zebrafish-M. marinum model [7]. Using this model, the bacterial 
RD1 locus was found to be required for efficient granuloma formation and that the ESX-1 system 
was responsible for the cell death of infected macrophages [8].
3. Molecules involved in pathogenesis and virulence
3.1. Mycobacterial lipids
Mycobacterial cell wall is rich in lipids and has exceptional physico-chemical properties as 
a strong impermeability; and even it has peptidoglycan on it, mycobacteria are acid fastness 
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organisms due to the large amount of lipids. In this section, we describe mycobacterial cell 
wall components and their relation with pathogenicity and virulence, the second part of 
the chapter is dedicated to study the phenomenon produced by some of the mycobacterial 
molecules.
3.1.1. Lipoarabinomannan (LAM)
Lipoarabinomannan (LAM) is a glycolipoconjugate composed by an anchor mannosyl phos-
phate inositol (MPI), a polysaccharide backbone and diverse capping motifs species [9]. 
Correct translocation of LAM in to the cell wall constitutes an important feature for the myco-
bacterial stability, the lack of O-manosilation was associated with increased production of 
LAM and increased release of LAM/LprG protein and consequently with a reduction in viru-
lence of MTB O-manosilated deficient strain [10]. Variation in the mannose-capped arabinan 
ManLAM motifs between LAM from different strains and clinical isolates, may be responsible 
of the production of interferon-γ (IFN-γ) in CD-1b-restricted cell lines; and also, in differ-
ences in adherence to macrophages [11]. LAM inhibits phagosome maturation characterized 
for the presence of immature phagosome marker rab5, and allows intracellular surviving. 
LAM is released in the macrophages and intercalates with endomembranes, phenomenon 
essential in order to block phagosome arresting and also, the delivery of lysosomal hydro-
lases via the molecule EEA1, which blocks impeding phagosomal acidification [12]. There 
are a large number of publications compiled in the review [13] that describe the cytokine 
expression activity trigger by LAM in macrophages and dendritic cells (DC). Although there 
are differences in methodology and results among the data; to compile, the 20 publications 
analyzed include: an increased expression of tumoral necrosis factor alpha (TNF-α) in most 
of the publications, increased of IL-10 in some of the data and results showed different IL-6 
and IL-12 expression. ManLAM from MTB induce the expression of IL-12 and apoptosis in 
macrophages [14], whereas in T cells, lipid microdomains suffer insertion of PILAM with no 
apparent interaction with a specific receptor, this phenomenon trigger Th2 cytokine produc-
tion and a decreased Th1 cytokine expression [15].
3.1.2. Lipomannan (LM)
Lipomannan (LM) is a multiglycosylated lipid or polymannosylated Phosphatidylinositol 
mannoside (PIM). LAM and LM coexist in the mycobacterial cell wall. LM has been con-
sidered an innate immunity antigen; tetra-acylated LM activates macrophages using TLR2/
TLR4 in a dependent way of MyD88. Di-acylated molecules regulate and inhibit the pro-
duction of NO secretion and cytokine in macrophages activated by lipopolysaccharide (LPS) 
[16]. LM purified from M. kansasii and M. chelonae in a CD14-TLR2-dependent mechanism, 
induce secretion and expression of mRNA of IL-8 and TNF-α in THP1 macrophages [17]. It 
had demonstrated that LM from M. kansasii, M. bovis bacillus Calmette-Guérin (BCG) and 
M. chelonae induced a dual function in macrophages: activation with surface expression of 
CD40, CD86; production of TNF and NO secretion in a TL2 MyD88 dependent way; and also, 
and inhibition of expression of TNF and IL-12p40 and NO in macrophages activated with 
lipopolysaccharide (LPS) in a TLR independent way [18]. LM from M. kansasii, M. chelonae 
Mycobacterium - Research and Development234
and MTB induced apoptosis and IL-12 in THP1 macrophages [14]. Tri-tetra-acylated forms 
of BCG LM were suggested as responsible of the pro-inflammatory response. Try-acyl LM 
response is dependent of TLR2/TLR1 and MyD88 TIRAP and produce IL12 and NO. In M. 
smegmatis, structural changes of LM and LAM unleash the loss of acid-fastness, faster killing 
by macrophages by THP1 macrophages and led to higher sensibility to antibiotics; whereas in 
MTB lead to an attenuated infectivity in mice and antibiotic sensibility [19].
3.1.3. Phosphatidylinositol mannosides (PIMs)
Phosphatidylinositol mannosides (PIMs) constitute a substantial component of the cell enve-
lope, precursor of LAM and LM. PIM has a variable number of mannose units and acyla-
tion, virulent species have high order PIM (5 or 6 mannoses) that contribute to the uptake 
of macrophages by mannose receptor (MR); lower order PIM with few mannoses interact 
with DC-specific intercellular adhesion molecule-3-grabbing non-integrin DC-SIGN from 
DC [20]. The acylation state of PIM can induce granuloma formation and cell recruiting in 
BCG infection; specifically PIM
4
, PIM
6
 were used, and the acyl chain was responsible for NKT 
recruitment [21]. In contrast, glycolipids from MTB as PIM and ManLAM inhibited CD4+ 
T cell activation by interfering in the phosphorylation and T cell receptor signaling [22]. 
Host inflammatory response such as TNF, IL-12p40 was inhibited by PIM in murine mac-
rophages through CD14-dependent and CD14-independent mechanisms [23]. PIM induced 
an increased presence in culture supernatants of alveolar epithelial cells (AEC) of the anti-
inflammatory cytokine transforming growth factor beta (TGF-β) and a significant production 
of reactive oxygen species (ROS) [24]. Diacyl-phosphatidylinositol dimannoside (Ac
2
PIM
2
), 
acylphosphatidylinositol hexamannoside (AcPIM
6
) and diacylphosphatidylinositol hexaman-
noside (Ac
2
PIM
6
) from virulent MTB stimulate and drive proliferation in bovine PBMC from 
M. bovis-infected cattle; also the IFN-γ expression in PBMC was increased only during exposi-
tion to AcPIM
6
 [25].
3.1.4. Trehalose-6,6´-dimycolate (TDM)
Trehalose-6,6´-dimycolate (TDM) also known as cord factor, is the most abundant and toxic 
lipid in the mycobacterial cell envelope. TDM is composed by two polar trehalose head group 
where two mycolic acids (MA) are esterified. MA variations constitute a strong determinant 
of the inflammatory response of TDM. TDM has biological functions, promoting angiogenesis 
[26], inhibits acidification of phagolysosome, prevents Ca2+ dependent phagosome-lysosome 
fusion and mycobacterial surface lipid removal, which increased trafficking of bacteria to the 
acidic compartments, causing 99% of killing in macrophages after 3 days of infection [27]. 
TDM coating beads produce a delayed maturation of phagosomes characterized by a non-
acidified and hydrolytically restricted phagosome [28]. Cytokine production in macrophages 
exposed to TDM has been extensively described; there are a high diversity number of pub-
lications about it. The effect of these molecules has been correlated with the innate, early 
adaptive response (humoral and cellular immunity); to resume: cytokines as IFN-γ, TNF-α, 
IL-4, IL-6, IL-10; chemokines as MCP1, IL-8, are induced as response to exposition of TDM 
[29]. Reduction in the expression of MHCII, CD1d, CD80, CD40 and CD96 in the surface of 
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macrophages is induced by the exposure of the cells to TDM [30]. Microspheres coated with 
TDM showed an increased expression of enzymes and matrix metalloproteinases; molecules 
associated with tissue remodeling and tissue destruction during caseating granulomas [31]. 
The inflammatory profile induced by TDM has been related with granuloma development 
and maintenance, this phenomenon is related with TDM, and is dependent of TNF-α and IL6 
expression; also C5a complement factor has been described as part of the granuloma mainte-
nance microenvironment molecule [32].
3.1.5. Phthiocerol dimycocerosate (PDIM) and phenolic glycolipids (PGL)
Phthiocerol dimycocerosate (PDIM) and phenolic glycolipids (PGL) include a group of 
related cell wall lipids, non-covalently bounded to the mycobacterial surface. PDIM and 
PLG are major virulence factors of mycobacteria. PDIM and PGL are molecules required 
for bacterial duplication during the acute phase [33]. PDIM is involved in mycobacterial 
resistance to detergents, and also is linked with the permeability and envelope solidity 
[34]. PDIM is present in M. marinum and species from the MTBC, but is absent in M. smeg-
matis; it contributes to the intracellular bacterial surviving, protecting them against the 
action of reactive nitrogen intermediates species, and regulates TNF-α expression [35]. 
Phagosome acidification resistance is caused by exclusion of vacuolar proton-ATPase in 
the phagosomal membrane; PDIM deficient mutants can also provoke macrophages death 
[36]. PDIM is involved in the phagocytosis dependent of receptor through a macrophage 
plasma membrane reorganization mechanism [37]. Recent findings suggest that PDIM 
and ESAT-6 protein act together to induce phagosome membrane damage and apoptosis 
[38]. PGL is produced principally by fast growing mycobacteria; most of MTB isolates and 
H37Rv are unable to produce it, phenomenon caused by a mutation in the phs15/1 gene. 
PLG1, an immunogenic glycolipid produced for all M. leprae isolates, contains a trisaccha-
ride moiety, different to the MTB PLG; and could be obtained from M. leprae from infected 
tissues. PLG1 is responsible for the demyelination and damage in the axons, confers neu-
rotoxic proprieties to the macrophages and increase the reactive nitrogen species (RNS) 
synthesis [39].
3.2. Secretion systems in mycobacteria
Molecular migration across the mycobacterial cell wall, constitute an important event 
related with the environment and host cells interaction. Mycobacterial waxy cell enve-
lope controls the molecular movement and the secretion of substances across this struc-
ture is dependent of specialized proteins systems, some of these protein structures will be 
described below.
3.2.1. The twin-arginine transporter (TAT transporter)
The twin-arginine transporter (TAT transporter) is located in the cytoplasmic membrane and 
transport folded proteins. This system is composed by three membrane proteins named as 
TATA, TATB and TATC. M. smegmatis deletion mutants to tatC and tatA showed a growth 
defect on agar, defective exportation to active beta-lactamases and hypersensitivity to 
Mycobacterium - Research and Development236
sodium dodecyl sulfate (SDS), reason that suggests that TAT genes could be good candidates 
for vaccines and drug development [40]. Mycobacterial phospholipases, virulence-related 
molecules encoding by plcA, plcB, plcC and plcD genes, are secreted by the twin-arginine 
transporter [41]. TAT system is involved in secretion of relevant proteins, as example; the 
secreted protein encoded by the Rv2525c gene, which is involved in the cell wall biogenesis, 
this protein is conserved in M. leprae and present in MTB, it has been described as impor-
tant for virulence and it is involved in the resistance to beta-lactam antibiotics [42]. The 
resuscitation-promoting factor, RpfB associated with the MTB reactivation stage, interacts 
with the virulence factor RipA, an endopeptidase protein secreted together with the chap-
erone MoxR1, which requires the TAT secretion system. Inhibition of this system increased 
the sensitivity to beta-lactam antibiotics and prevents the localization of the peptidoglycan 
hydrolase [43].
3.2.2. The ESX transporter
The ESX transporter has no counterpart in LPS bacteria; it is located in the cytoplasmic mem-
brane and exports and secretes proteins across the mycobacterial cell envelope. ESX genes are 
encoded at the genome and plasmids [44] and codify to for ESX type proteins EspA, EspB, 
EspC, EspG, etc, the secreted proteins ESAT-6 y CFP-10; PE-PPE; and the conserved com-
ponents EccB, EccC, EccD and MycP [45]. The ESX systems are named as ESX-1 to ESX-5, 
depending on the variation of the diverse systems and their components.
3.2.2.1. ESX-1
ESX-1 transporter system is important during mycobacterial infection in MTB and other 
pathogenic mycobacteria, in BCG the loss of the region of difference 1 (RD1) and the partial 
loss of the ESX-1 encoding region is related with the attenuation of the strain [46]. ESX-1 
allows cytosolic contact and mediates vacuoles rupture [47]; the protein intervenes in host cell 
lysis in a contact dependent way, producing gross membrane disruptions [48]. DNA trans-
fer through conjugation is also a function of ESX-1 system [49]; a phenomenon called “dis-
tributive conjugal transfer” that describes a genetic exchange between recipient and donor is 
dependent of ESX-1 in M. smegmatis [50]. espB gene located in the RD1 region has been related 
with cytotoxicity and their presence in the surface of apoptotic cells for clearance by macro-
phages through efferocytosis [51].
3.2.2.2. ESX-3
ESX-3 is involved in Zn and Fe uptake. ESX-3 proteins: EsxG and EsxH are associated with 
the (proline-glutamic acid, proline-proline-glutamic acid) PE and PPE secretion [52]. The EsxG 
and EsxH heterodimer, which harms macrophage phagosome maturation, is secreted by the 
ESX-3 system [53] and inhibits the endosomal-sorting complex required for transport (ESCRT) 
impairing MTB antigen-specific CD4+ activation by macrophages and DC [54]. In M. abscessus 
ESX3 is composed by the genes esxH, esxG, esx-3, EsxG and EsxG proteins are related with 
enhancement of inflammatory cytokine generation in macrophages, M. abcessus esx3 mutant 
resulted in less inflammatory response [55].
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3.2.2.3. ESX-5
ESX-5 secretion system only present in slow-growing mycobacteria is linked to PPE and PE 
exportation and pathogenicity. The secretion mechanism of ESX-5 is activated in response to 
phosphate limitation through phosphate sensing of Pst/SenX3-RegX3 system [56]. In MTB, 
disruption of ESX-5 showed a strong attenuation, failure in the cell wall integrity and the loss 
of the secretion of the PPE protein [57]. ESX-5a region, from ESX5 is composed by duplicated 
genes and had been related with inflammasome activation [58]. Also, mutations in the ESX-5 
system components as esxC5 are related with ofloxacin resistance in MTB [59].
3.3. PE proteins: PE-PPE and PE-PGRS
The PE domain permits transportation of proteins, which share the domain. PE-PGRS and 
PE-PPE interacts with the TLR-2 on DC and macrophages, inducing: cytokine secretion, 
necrosis and apoptosis and enhance mycobacterial survival [60]. PE-PGRS33 interaction with 
TLR mediates macrophage entry [61]. PE-PGRS30 mutant showed an attenuated phenotype, 
specifically inhibits phagosome-lysosome fusion and showed decreased lung colonization 
and reduced tissue damage [62]. PE-PGRS32 gene is highly conserved in MTB strains, because 
it has been related with mycobacterial survival in macrophages, persistence and replication 
[63]. PPE10 has been described as an ESX-5 substrate in pathogenic mycobacteria; muta-
tion of both of them reduced the envelope integrity and mycobacteria hydrophobicity [64]. 
Co-localization of PE-PGRS33 in the host cell mitochondria induces cell death: necrosis and 
apoptosis [65]. PE-PGRS47 disruption led to an in vitro and in vivo attenuated growth and 
autophagy inhibition in infected phagocytes [66].
3.4. Lipoproteins
MTB genome analysis showed around 90 putative lipoproteins, most of them are part of the 
mycobacterial cell envelope and the plasma membrane; their function is related with molecu-
lar exportation, cell wall homeostasis and nutrient uptake; their presence contribute to host-
pathogen interaction.
3.4.1. LpqH (19 kDa protein)
This lipoglycoprotein O-glycosylated and acylated, is a major cell wall antigen. LpqH is 
recognized by the immune system and induces T cell proliferation in vitro, stimulates DC 
maturation and autophagy and activates TLR-2 [67]. The protein alters the expression and 
presentation of antigens by MHCII [68]. 19kDa protein, induces macrophage apoptosis by 
caspase-dependent and -independent mechanisms with activation of the initiator caspase 8 
and executioner caspase 3 [69]. DC that phagocyte apoptotic macrophages induced by cell 
wall extract expressing LpqH, activates CD8 T cells through cross-presentation [70].
3.4.2. LppX
LppX is related with the release of complex lipids to the culture filtrate; LppX structure 
showed a large cavity that probably binds big motifs as the one present in PDIM. In a mice 
model, LppX-deficient mutant showed attenuation [71].
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3.4.3. Mpt83
Mpt83 glycosylated lipoprotein related with host cell adhesion, is present in MTB and M. 
bovis and both proteins are identical, but with some glycosylation differences. Protein is rec-
ognized by the MR, and the native protein induces IL-6, IL-12 and TNF-α [72]. T cell prolifera-
tion and IFN-γ expression was detected in PBMCs from donors vaccinated with BCG or with 
latent tuberculosis after exposition to non-lypidated synthetic Mpt83 [73].
3.4.4. LprG
LprG also known as P27 lipoprotein, is a ligand of TLR2; inhibits antigen processing in 
macrophages MHC II [74]. It has a large cavity that binds triacylated agonist of TLR2: 
LM, LAM and PIM [75]; and determines LAM envelope localization and control phago-
some-lysosome fusion [76]. Expressed in an operon with Rv1410c, binds triacylglyceride 
(TAG) in the cavity and regulates TAG levels, growth rate and virulence [77]. Involved in 
cell wall composition, MTB mutant deleted lprG showed a decreased amount of surface 
LAM, affecting interaction with the MR and host cells, phagosome-lysosome fusion dis-
turbance, and in mice model showed a decreased number of bacteria in the lungs. [78]. 
M. bovis P27 is required for arresting phagosome maturation and replication in bovine 
macrophages [79].
3.4.5. RpfB
RpfB multidomain lipoprotein related with resuscitation after mycobacterial dormant state 
drives in DC Th1-type immunity through interaction with TLR-4 [80].
3.4.6. LpqS
LpqS MTB protein conserved in slow-growing pathogenic mycobacteria, is a protein related 
with survival during latency. LpqS mutant showed attenuated virulence in guinea pig mod-
els and provide better immunization against pulmonar tuberculosis in comparison with 
BCG [81]
3.4.7. LprN
LprN lipoprotein related with cellular entry and survival, is part of the mce4 operon. 
Recombinant LprN expressed in E. coli, showed in in vivo assays on mice, an increased expres-
sion of IFN-γ and TNF-α, and also a higher T cell proliferation, but failed to protect mice 
against MTB challenge [82].
3.4.8. Lprl
Lprl lipoprotein present only in bacteria from MTBC, showed upregulation during myco-
bacterial macrophage infection. Lprl strongly attaches lysozyme, annulling completely their 
enzymatic activity. Lprl expression in M. smegmatis enhanced phagocytosis and survival in 
macrophages derivate from peritoneal monocytes; also protect the bacteria against lysozyme 
activity [83].
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3.4.9. PstS
PstS phosphate transporter, glycolipoprotein, is recognized by MR, induces phagocytosis and 
reduces the production of ROS [84]. PstS-1, PstS-2, PstS-3 DNA vaccine was used in mice, only 
animals vaccinated with PstS-3 showed reduction of CFU on lungs and spleen [85].
4. Immune system evasion
Unlike other pathogens, MTB infects and resides within immune cells, this bacterium has the 
ability to live within the dynamic and heterogeneous environment of macrophage phago-
some. Here, the bacilli use a plethora of strategies to evade the microbicidal mechanisms 
of macrophage, including: phagosome-lysosome fusion, recruitment of hydrolytic lysosomal 
enzymes, production of reactive oxygen/nitrogen species, antigen presentation and apoptosis. 
Disruption of those functions in turn disrupts the adaptive immune response. Phagocytosis is 
an active process that depends on the interaction with various surface receptors expressed on 
the macrophage such as complement receptor type 3 (CR3), FCγ receptors and lectin recep-
tors and it can be opsonic or non-opsonic. However, non-opsonic phagocytosis of MTB results 
in higher intracellular survival, although it is difficult to assess if the engagement of specific 
receptor determines the course of infection [86]. MTB uses PDIM lipids to evade detection by 
TLRs, thereby preventing mycobacterial delivery into microbicide macrophages expressing 
iNOS [33]. Moreover, MTB actively blocks the phagosome maturation by their cell wall com-
ponents or through the secretion of various macromolecules that interferes with this process, 
which enables bacterial survival in a non-acidified intracellular compartment [12].
4.1. Phagosome arresting
PtpA and SapM are two phosphatases that contribute with the phagosome arresting. PtpA 
binds to subunit H of the vacuolar V-ATPase in order to dephosphorylate its substrate, the 
vacuolar protein sorting 33B (VPS33B) resulting in the exclusion of V-ATPase from myco-
bacterial phagosome thus inhibiting phagosome acidification [87]. MTB mutant in PtpA was 
severely attenuated when infecting THP-1 cell line compared with wild type strain, these 
results show that PtpA is essential for mycobacteria survival within macrophage [88]. SapM 
is a secretory phosphatase that dephosphorylates phosphatidylinositol 3-phosphate (PI3P) on 
the phagosome membrane [87]. PI3P is essential for phagosomes to acquire lysosomal con-
stituents; it is involved in the docking of rab effector proteins early endosomal autoantigen 
1 (EEA1) and hepatocyte growth factor-regulated tyrosine kinase (HRS) substrate, which are 
important for phagosome maturation [89]. Disruption of sapM in MTB resulted in a highly 
attenuated strain with an impaired ability to grow in the THP-1 macrophages as well as in the 
guinea pig tissues [33].
Ndk is a nucleoside diphosphate kinase with ATP- and GTP-binding activity and it is widely 
conserved across all the three domains of life. This protein is autophosphorylated and secreted 
into the culture medium by MTB and possesses GAP activity towards Rho GTPases Rab5 and 
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Rab7, leading to reduced phagolysosome fusion [90]. Besides, Ndk also targets and inacti-
vates the small GTPase Rac1, an essential component of the macrophage NADPH oxidase 
(NOX2) complex, inactivation of Rac1 was associated with reduced NOX2-mediated produc-
tion of reactive oxygen species (ROS) and ROS-dependent apoptosis thus contributing signifi-
cantly to mycobacterial virulence [91]. Another factor crucial for inhibition of phagolysosome 
fusion is the serine/threonine protein kinase G (PknG). In contrast to other mycobacterial 
kinases, autophosphorylation on Thr residues at the N terminus of PknG are not involved in 
the regulation of this kinase; however, it is essential for the capacity of PknG to block lyso-
somal delivery of mycobacteria and for the bacterial survival in murine BMDM [92].
The PE_PGRS protein family includes around 60 proteins but the role and function of these 
proteins remains elusive. Nonetheless, PE-PGRS30 was the first PE-PGRS protein with a cer-
tain role in the virulence of MTB. PE_PGRS30 mutant was impaired in its ability to colonize 
lung tissue and to cause tissue damage; and inactivation of PE_PGRS30 resulted in an attenu-
ated phenotype in murine and human macrophages due to the inability of the MTB mutant to 
inhibit phagosome-lysosome fusion [62].
Several factors have been implicated in phagosome maturation arrest, such as LAM, TDM, 
LpdC, Zmpq and the Esx-1 secretion system [27, 93–95]. But more importantly it seems that 
the requirement for these processes in the different mycobacterial species may not necessarily 
be identical; for example, BCG is able to arrest phagosome maturation in spite of the absence 
of RD1 locus, thus phagosome arresting in the case of BCG can be without ESAT-6 and CFP-
10 although these proteins are necessary for this arrest in M. marinum [94, 96]. Therefore it is 
noteworthy that phagosome maturation and its arrest are complex processes with multifacto-
rial requirements.
4.2. Resistance to reactive oxygen and nitrogen species
Upon phagocytosis of mycobacteria, macrophages produce antimicrobial reactive oxygen and 
nitrogen species (ROS and RNS) via the enzymatic activity of NADPH oxidase (NOX2) and 
inducible nitric oxide synthase (iNOS), respectively. NOX2 is a multiprotein enzyme complex 
that assembles and activated in response to phagocytosis. This enzyme complex transfers 
electrons across the membrane from cytosolic NADPH to molecular oxygen, the reaction pro-
duce superoxide anions (O
2
−) which dismutates into hydrogen peroxide (H
2
O
2
) and generates 
toxic hydroxyl radicals [48]. iNOS is induced upon IFN-γ activation and produces nitrite and 
nitrate via nitric oxide (NO), this reacts with O
2
− and forms peroxynitrite (OONO−) [97]. This 
reactive oxygen and nitrogen intermediates (ROI and RNI) react with a wide range of mol-
ecules, such as nucleic acids, proteins, lipids and carbohydrates, thus for intracellular patho-
gens like MTB survival upon exposure to oxidative stress is critical.
Among the factors that contribute to MTB success as a pathogen are: its ability to survive 
the redox stress manifested by the host and its capacity synchronize its metabolic pathways 
and expression of virulence factors. Two component proteins, namely DosS and DosT, are 
employed by MTB to sense changes in oxygen, nitric oxide and carbon monoxide levels, 
while WhiB3 and anti-sigma factor RsrA are used to monitor changes in intracellular redox 
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state [98, 99]. Using these and other unidentified redox sensors, mycobacterium orchestrates 
its metabolic pathways to survive in nutrient deficient, acidic, oxidative, nitrosative and 
hypoxic environments inside granulomas or infectious lesions [97]. MTB employs versa-
tile machinery of the mycothiol and thioredoxin systems to ensure a reductive intracellular 
environment for optimal functioning of its proteins even upon exposure to oxidative stress 
[97]. Mycothiol is a low-molecular-weight thiol and functions like glutathione, the archetypal 
redox buffer, which is not produced by mycobacteria. Therefore it has antioxidant activity as 
well as the ability to detoxify a variety of toxic compounds. The thioredoxin (Trx) system is 
composed of NADPH, thioredoxin reductase (TrxR), and Trx is a small redox protein with 
two redox-active Cys residues in its active site [100]. Trx is responsible for maintaining a 
reducing intracellular environment, regenerating the reduced forms of methionine sulfoxide 
reductase and peroxiredoxins, as well as the redox regulation of enzymes and regulatory 
proteins by oxidoreduction and the detoxification of ROS [100]. MTB contains three types 
of Trx, although TrxB is the only one essential to fight against host defenses and for in vitro 
growth [101]. Additionally, mycobacterium employs a battery of protective enzymes, such 
as superoxide dismutase (SOD), catalase (KatG), alkyl hydroperoxidase (AhpC) and per-
oxiredoxins to detoxify and neutralize these redox stresses [97]. SOD is a metalloprotein 
produced by prokaryotes and eukaryotes to detoxify superoxide radicals. This enzyme dis-
mutates O
2
− into H
2
O
2
 and molecular oxygen and has been shown to contribute to the viru-
lence in a number of pathogens, including MTB, which have two genes, sodA and sodC [97]. 
Pathogenic mycobacterium species express and secrete higher levels of SodA compared to 
the non-pathogenic species. In fact, MTB mutants with reduced SodA expression displayed 
increased susceptibility to H
2
O
2
 and were markedly attenuated in mice [102]. Although 
SodA lacks a classical signal sequence for protein export, it is a protein dependent on SecA2 
for secretion. MTB mutants in secA2 are defective in the export of SodA and KatG, and are 
unable to grow in non-activated macrophages and showed reduced growth in mice [103]. 
SodC is a Cu/Zn superoxide dismutase anchored in the outer-membrane to protect MTB 
from reactive oxygen intermediates at the bacterial surface. Mutants in sodC show decreased 
survival in IFN-γ-activated murine peritoneal macrophages and have increased sensitivity 
to hydrogen peroxide [104].
Catalase peroxidases are enzymes that protect the bacterium from ROS damage and are used 
to detoxify H
2
O
2,
 KatG from MTB degrades H
2
O
2
 and organic peroxides. Thus the major role 
of KatG in TB pathogenesis is to catabolize the peroxides generated by the phagocyte NADPH 
oxidase; although in the absence of this host antimicrobial mechanism, KatG is apparently dis-
pensable [105]. Moreover, KatG also activates the anti-tuberculosis drug isoniazid (INH) con-
verting it to several reactive species that inhibits a mycolic acid biosynthesis [105]. Although 
isoniazid resistance is multigenic, mutations in katG predominate among the INH-resistant 
strains, but the effect of these mutations on MTB virulence is variable. In general, katG muta-
tions render MTB strains sensitive to endogenous or exogenous peroxides, generated during 
bacteria respiration or by phagocytes during infection [105], maybe because mutations also 
affect the peroxidase domain of KatG [106] though the activity of the alkyl hydroperoxidase 
C (AhpC) has been described as an important compensatory mechanism in INH-resistant 
strains [107].
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AhpC is a member of the peroxiredoxin family that detoxifies organic peroxides into less reac-
tive alcohol derivatives and confers protection against both oxidative and nitrosative stress. 
AhpC mutants show an essential role in the resistance to host oxidative agents in the early 
stages of infection [108]. Besides, phenotypic M. bovis mutants producing less AhpC were less 
virulent in guinea pig model than the wild type [109].
Peroxiredoxins (Prx) proteins are multifunctional antioxidant enzymes that reduce and thus 
detoxify hydroperoxides, organic hydroperoxides and peroxynitrite using electrons from Trx. 
Five Prx enzymes have been identified in MTB: AhpE, TPx, AhpC, Bcp and BcpB [97]. Tpx 
is the principal and most effective enzyme involved in the detoxification of H
2
O
2
 and per-
oxynitrite in mycobacteria. In macrophages, the tpx mutant shows impaired replication in 
activating and resting cells, and in mice the mutants were less lethal and persistent that the 
wild-type strain [110].
Deletion of genes that encode methionine sulfoxide reductase (msrA), Mtb proteasome 
(prcBA), nucleotide excision repair (uvrB) and F-420 biosynthesis (fbiC) are also hyper-sus-
ceptible to RNS [111]. Likewise, α-crystalline (HspX), bacterioferritin (bfrB) and the DosR 
regulon are upregulated by conditions that inhibit aerobic respiration; however, their role in 
MTB virulence is little understood [1].
4.3. Inhibition of apoptosis
During MTB infection, several forms of cellular fates have been observed such as necroptosis, 
apoptosis and autophagy, among those, apoptosis and autophagy have been recognized as 
innate macrophage defense mechanisms. Apoptosis is highly regulated process where the 
cytoplasm and other cellular organelles of dying cell are enclosed in membrane bound vesi-
cles called apoptotic bodies. The apoptotic bodies are taken up by macrophages via receptor-
mediated phagocytosis in a process defined as efferocytosis without elicit any inflammatory 
response [112].
Apoptosis reduces the viability of different mycobacterial species, including MTB; in fact 
many attenuated strains of mycobacteria induce more apoptosis than their wild type counter-
parts and exists a reciprocal relationship between virulence and apoptosis [113]. MTB infec-
tion mainly results in necrosis, while attenuated mutant strains including BCG and H37Ra 
primarily induce apoptosis [113]. Most of the factors that have been described as anti-apop-
totic molecules play roles in the bacterial redox homeostasis (katG, sodA, secA2 and pknE) 
because phagosome ROS promotes the apoptosis.
The nuoG gene of MTB encodes the NuoG subunit of the type I NADH dehydrogenase (NDH-1) 
that is important in the inhibition of host macrophage apoptosis, since MTB mutant-induced 
apoptosis in human THP-1 cells. Moreover, BALB/c and SCID mice infected with this mutant 
survived longer and the bacterial load in lungs were smaller than of the wild-type strain [114]. 
In addition, MTB can neutralize ROS in order to inhibit TNF-mediated host cell apoptosis via 
a NuoG-dependent mechanism [115]. Similar function can also be observed for SecA2, which 
is the ATPase of the canonical bacterial Sec secretion system, and as stated above SecA2 is 
required for intracellular growth of MTB in macrophages preventing phagosome maturation 
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[116]. Mutant of MTB in secA2 induces more apoptosis than wild type in infected macrophages, 
but more importantly the author shows that SodA secretion was the major SecA2 process 
involved in the inhibition of apoptosis [117]. Therefore, it can assume that the SecA2 secretion 
system, most likely through SodA, inhibits apoptosis in a mechanism probable independent of 
oxidative burst [118].
The serine/threonine kinase E, pknE contributes to the survival response of MTB by regulat-
ing the bacilli machinery to resist apoptosis during nitrate stress. Deletion of pknE results in 
a mutant that was more susceptible to NO exposure, inducing higher level of apoptosis than 
wild-type strain and less production of TNF-α and IL-6. However, further in vivo studies are 
needed to establish the role of PknE in the virulence of MTB [119].
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